State budget forbids public funds being used on these procedures
The Medical University of South Carolina will no longer inject transgender drugs into gender-confused minors.
The university will stop accepting new patients beginning Aug. 1 and stop all procedures by January 2025 to comply with House Bill 4624.
“Public funds may not be used directly or indirectly for gender transition procedures,” according to the legislation.
“MUSC Health funds are public funds. We are prohibited from providing gender transition services to all patients,” CEO Patrick Crawley said, according to the South Carolina Daily Gazette.
“A physician who knowingly performs genital gender reassignment surgery in violation of this chapter is guilty of inflicting great bodily injury upon a child,” the bill also states.
The university reportedly does not commit the surgeries, which are intended to make boys look like girls and vice versa.
Surgeries, such as breast removal, are irreversible and can leave a woman unable to nurse her child in the future.
The university previously halted the prescription of drugs for minors to comply with a budget rider in 2022, as previously reported by The College Fix.
The drugs and surgeries have come under scrutiny in recent years, as their safety has been called into question.
Furthermore, biologists have confirmed that there are only two sexes and it is immutable.
Medical groups that facilitate access to the drugs have also come under scrutiny for lax standards.
A producer for Daily Wire show host Matt Walsh was able to get permission to have testicles removed. Gregg Re faked his way through a call with Plume Health and obtained the letter in just 22 minutes, despite multiple red flags.
Similarly, the Washington Free Beacon reported on how a Planned Parenthood facility prescribed estrogen drugs to a teenager with autism, without his parent’s knowledge.
“Instead of a months-long evaluation by expert psychiatrists, a nurse practitioner had, in little over 30 minutes, prescribed their special-needs son a powerful drug without their knowledge or consent,” the Free Beacon reported in Oct. 2023.
An independent review by Dr. Hilary Cass, commissioned by the National Health Service in England, also criticized the procedures.
“The rationale for early puberty suppression remains unclear, with weak evidence regarding the impact on gender dysphoria, mental or psychosocial health,” Cass wrote. “The effect on cognitive and psychosexual development remains unknown.”
“Clinicians are unable to determine with any certainty which children and young people will go on to have an enduring trans identity,” Cass wrote.
Elsewhere the review also expressed skepticism about the procedures and the quality of evidence behind them.
MORE: Catholic Georgetown to offer ‘gender-inclusive’ housing in the fall
IMAGE: Wirestock/Getty Images with College Fix edits
Please join the conversation about our stories on Facebook, Twitter, Instagram, Reddit, MeWe, Rumble, Gab, Minds and Gettr.